“Every day, new developments arise regarding cancer treatment,” says Dr Echt, founder and lead oncologist of Choice Cancer Care

“We have industry-best medical oncologists, along with radiation oncologists who’ll closely work with you every step of the way.”

The study that arrived at the findings involved nearly 30,000 patients age 66 and older who had been diagnosed with non-metastatic breast cancer.

While smoking remains the number one risk factor for lung cancer, it isn’t the only one. Exposure to environmental pollutants, workplace chemicals and asbestos may all promote the development of lung cancer.

The American Cancer Society is responsible for the report that indicates the number of survivors is steadily growing.

The PSA is designed to measure the levels of prostate-specific antigen in men’s blood. This antigen is often associated with the development of prostate tumors.

The new test, called MammaPrint, is a 70-gene signature screen that helps doctors identifies patients who are at high clinical risk, but low genomic risk.

A recent study shed light on the spike in care costs. One portion of the study focused on the 11 new drugs that have been introduced in recent years to fight metastatic breast cancer.

The study was conducted as a significant rise in the number of women seeking mastectomies even in early stages has been witnessed.

People who are obese will find medical professionals do have a variety of tools available to help obese patients address weight-related concerns.

A recent study into the use of a program called InSight showed promising results in regard to chemo brain. Patients reported marked improvements in cognitive testing scores after using the program for about 15 weeks.

An estimated 246,000 American women will be diagnosed with breast cancer in the coming year. About 40,000 women will die from the disease. Early screening is considered a critical step in increasing survival chances should this disease develop.

To determine if mammogram findings could be extrapolated to indicate concerns related to heart disease, a study was recently conducted.

The moonshot features a number of prongs that make it different than any other research push to date. In addition to more than $1 billion in funding, the program is being driven by a Cancer Moonshot Task Force.

Proton beam therapy’s use is on the rise in regard to the treatment of several different cancers. It is especially favored when tumors present in delicate, easy-to-damage areas, such as the prostate.

Announced earlier this year, the cancer moonshot was created on the heels of Vice President Joe Biden’s son Beau’s death.

Mammograms are currently recommended on an annual basis for women age 40 to about 49. Women age 50 to 74 will find the recommendation drops to about once every two years for the test.

The goal of proton beam therapy is the same as standard radiation. Both are designed to eradicate cancer by irradiating cells.

The recent study looked at 80 patients who underwent radiation treatments after lung cancer surgery. A few patients also had chemotherapy, as well.

Cutaneous squamous cell carcinoma is the second most commonly diagnosed form of skin cancer in the United States.